Page last updated: 2024-11-07

dibenzylchlorethamine and Cardiomyopathies

dibenzylchlorethamine has been researched along with Cardiomyopathies in 1 studies

Dibenzylchlorethamine: An alpha adrenergic antagonist.

Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jasmin, G1
Bajusz, E1

Other Studies

1 other study available for dibenzylchlorethamine and Cardiomyopathies

ArticleYear
Prevention of myocardial generation in hamsters with hereditary cardiomyopathy.
    Recent advances in studies on cardiac structure and metabolism, 1975, Volume: 6

    Topics: Alkaline Phosphatase; Animals; Cardiomyopathies; Cricetinae; Dibenzylchlorethamine; Female; Male; Mu

1975